AstraZeneca PLC (OTCMKTS:AZNCF) Short Interest Update

AstraZeneca PLC (OTCMKTS:AZNCF) was the target of a significant decrease in short interest in June. As of June 15th, there was short interest totalling 12,200 shares, a decrease of 41.9% from the May 31st total of 21,000 shares. Based on an average daily volume of 3,600 shares, the days-to-cover ratio is currently 3.4 days.

Institutional Trading of AstraZeneca

A hedge fund recently bought a new stake in AstraZeneca stock. Kennedy Capital Management LLC bought a new stake in AstraZeneca PLC (OTCMKTS:AZNCF) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 37,554 shares of the company’s stock, valued at approximately $5,068,000. Hedge funds and other institutional investors own 40.87% of the company’s stock.

AstraZeneca Price Performance

Shares of AZNCF opened at $158.64 on Friday. AstraZeneca has a 1 year low of $118.16 and a 1 year high of $162.00. The company’s 50-day simple moving average is $153.62 and its 200-day simple moving average is $139.65.

About AstraZeneca

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.